Other Clinical Trial - Efficacy & Safety Study of I10E in Treatment of

Updated 06/21/2024

Status Completed

Clinical Trial Summary

Primary objective: To assess the efficacy of I10E in improving the disability of patients with CIDP. Secondary objective: To assess the safety of I10E in patients with CIDP.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Polyradiculoneuropathy
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

Clinical Trial Details

NCT number	NCT02293460
Study type	Interventional
Source	Laboratoire français de Fractionnement et de Biotechnologies
Contact
Status	Completed
Phase	Phase 3
Start date	May 2015
Completion date	September 29, 2017

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT04356781` - Do IgG Level Variations in CIDP and MMN Patients Following Initial Intravenous IVIg Treatment Correlate With Ultimate Dosing
	Recruiting	`NCT04561557` - Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System	Early Phase 1
	Terminated	`NCT01225276` - Safety and Efficacy Study of Three Different Dosages of NewGam in Patients With CIDP	Phase 2/Phase 3
	Completed	`NCT02892890` - Exploratory Study of Predictive Markers of the Therapeutic Response in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy Treated With Intravenous Immunoglobulin	N/A
	Active, not recruiting	`NCT03584022` - Clinical Trial to Assess the Safety of a Novel Scaffold Biomaterial	N/A
	Terminated	`NCT02317562` - Efficacy and Safety Study of I10E in the Maintenance Treatment of Patients With CIDP: Extension of PRISM Study I10E-1302	Phase 3
	Recruiting	`NCT06325878` - Genetic Architecture of Chronic Inflammatory Demyelinating Polyradiculoneuropathy	N/A
	Recruiting	`NCT06290128` - A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work	Phase 3
	Completed	`NCT02017769` - MRI in Diagnosing and Monitoring CIDP	N/A
	Withdrawn	`NCT05257733` - Evaluation of the Diagnostic Contributions of Nerve Ultrasound in Chronic Inflammatory Demyelinating Polyneuropathy Associating Systemic Diseases (CIDP Echo-nerf)
	Completed	`NCT03967899` - Study of Electrical Prognostic Factors of Response to Intravenous Immunoglobulin Treatment in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
	Not yet recruiting	`NCT04978623` - Role of High Frequency Ultrasound in Demyelinating Polyneuropathies
	Active, not recruiting	`NCT02404298` - Transcriptome Analysis of the Peripheral Blood in CIDP	N/A
	Completed	`NCT00099489` - Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)	Phase 2
	Completed	`NCT01625182` - Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients.	Phase 3
	Completed	`NCT02549170` - A Study of HyQvia and Gammagard Liquid (Kiovig) in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)	Phase 3
	Completed	`NCT02955355` - Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDP	Phase 3
	Active, not recruiting	`NCT04658472` - Proof-of-concept Study for SAR445088 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)	Phase 2
	Withdrawn	`NCT04529291` - InertiaLocoGraphy as a Biomarker of Immunoglobulin Therapy Efficacy in Chronic Inflammatory Demyelinating Polyradiculoneuropathy	N/A